New Ozempic-alternative diabetes pill burns fat without muscle loss, study suggests
Fox News senior medical analyst Dr. Marc Siegel discusses advancements in weight loss drugs, safety concerns surrounding nicotine patches and his interview with FDA Commissioner Dr. Marty Makary on vaccine protocol.
TL;DR
- A new pill developed by Swedish scientists targets fat burning and blood sugar control by boosting muscle metabolism.
- Unlike GLP-1 drugs that suppress appetite, this medication works directly on muscles.
- Early studies in animals showed it controlled blood glucose, increased fat burning, and maintained muscle mass.
- Human trials with healthy adults and individuals with type 2 diabetes showed good safety and tolerability.
- The new drug is noted to have fewer side effects compared to GLP-1 medications like semaglutides and tirzepatides.
- It utilizes a new form of beta-2 agonist that benefits muscle function without overstimulating the heart.
- The medication can potentially be used alone or in combination with GLP-1s.
- Researchers believe it could be significant for patients with type 2 diabetes and obesity, potentially preserving muscle mass linked to life expectancy.
- Larger phase 2 trials are planned to include people with obesity.
- The study was supported by several research councils and foundations, with collaborations from multiple universities.